Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study
- PMID: 2684523
- DOI: 10.1159/000417896
Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study
Similar articles
-
Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease.Contrib Nephrol. 1989;76:227-40; discussion 240-1. doi: 10.1159/000417899. Contrib Nephrol. 1989. PMID: 2684524 Clinical Trial. No abstract available.
-
Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.Contrib Nephrol. 1989;76:166-78; discussion 212-8. Contrib Nephrol. 1989. PMID: 2684519 Clinical Trial. No abstract available.
-
Dose-finding, double-blind, clinical trial of recombinant human erythropoietin (Chugai) in Japanese patients with end-stage renal disease. Research Group for Clinical Assessment of rhEPO.Contrib Nephrol. 1989;76:179-92; discussion 212-8. doi: 10.1159/000417894. Contrib Nephrol. 1989. PMID: 2684520 Clinical Trial. No abstract available.
-
[Erythropoietin, blood viscosity and hypertension in chronic kidney failure].Dtsch Med Wochenschr. 1989 Jun 30;114(26):1046-9. doi: 10.1055/s-0029-1235699. Dtsch Med Wochenschr. 1989. PMID: 2661190 Review. German. No abstract available.
-
Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.Kidney Int Suppl. 1993 Feb;40:S111-9. Kidney Int Suppl. 1993. PMID: 8445832 Review. No abstract available.
Cited by
-
Hypoxia-Inducible Factor Stabilizers: a New Avenue for Reducing BP While Helping Hemoglobin?Curr Hypertens Rep. 2016 Mar;18(3):23. doi: 10.1007/s11906-016-0629-6. Curr Hypertens Rep. 2016. PMID: 26894597 Review.
-
Impact of higher hemoglobin targets on blood pressure and clinical outcomes: a secondary analysis of CHOIR.Nephrol Dial Transplant. 2012 Sep;27(9):3606-14. doi: 10.1093/ndt/gfs123. Epub 2012 May 9. Nephrol Dial Transplant. 2012. PMID: 22573238 Free PMC article. Clinical Trial.
-
Cost benefits of low dose subcutaneous erythropoietin in patients with anaemia of end stage renal disease.BMJ. 1992 Feb 22;304(6825):474-7. doi: 10.1136/bmj.304.6825.474. BMJ. 1992. PMID: 1547417 Free PMC article.
-
Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients.PLoS One. 2013 Dec 31;8(12):e84848. doi: 10.1371/journal.pone.0084848. eCollection 2013. PLoS One. 2013. PMID: 24391978 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical